Respiratory Infection

Researchers link changes in lipids to human health, disease, and aging

By Nick Paul Taylor

Researchers have tracked changes to lipids during respiratory viral infection, insulin resistance, and aging, suggesting that the fats may play a role in immune homoeostasis and inflammation regulation.

September 13, 2023

Lab billing firm settles lawsuit related to unnecessary COVID-19 testing

By LabPulse.com staff writers

For one chain of communities, a laboratory directed the company to bill Medicare for respiratory pathogen panels ordered by a physician who had not ordered the tests.

June 20, 2023

Simple Healthkit at-home testing kits on Walmart.com

By LabPulse.com staff writers

The service starts with diagnostic testing -- at-home, in clinics, or at the pharmacy -- and is enabled by reliable tests with fast results, Simple Healthkit said.

June 12, 2023

Arkansas man sentenced in $134M healthcare fraud, money laundering scheme connected with lab testing

By LabPulse.com staff writers

With colleagues, the man submitted more than $134 million in false and fraudulent claims to Medicare in connection with diagnostic laboratory testing during the COVID-19 pandemic.

June 9, 2023

Medical records link vaccination against COVID-19 to reduced risk of non-respiratory symptoms

By Nick Paul Taylor

An analysis, details of which were presented Tuesday at the ATS 2023 International Conference in Washington, DC, reviewed data from 63,454 patients who were treated in a University of California medical center for COVID-19.

May 23, 2023

A. Menarini launches full automated MDx platform at WorldLab-EuroMedLab

By LabPulse.com staff writers

The system, Prime MDx, is an all-in-one, sample-to-result platform designed to allows users to process a variety of sample types through real-time polymerase chain reaction (PCR), the Florence, Italy-based firm said.

May 23, 2023

Qiagen launching syndromic molecular diagnostic system with respiratory panel in Japan

By LabPulse.com staff writers

Qiagen said Monday that its QIAstat-Dx syndromic testing system is expected to be available soon in Japan with a SARS-CoV-2 Respiratory Panel that can detect more than 20 pathogens from a patient sample.

April 24, 2023

BD nabs FDA authorization for SARS-CoV-2, influenza A/B, RSV combination test

By LabPulse.com staff writers

The test uses a single nasal or nasopharyngeal swab sample to identify and distinguish whether a patient has COVID-19, the flu, RSV, or some combination of the three, with results available in two hours.

February 8, 2023

Virax introduces rapid test kit for RSV, influenza A/B, COVID-19

By LabPulse.com staff writers

Virax Biolabs announced the distribution of a rapid antigen test kit capable of detecting when individuals have been infected with RSV, Influenza A/B, or COVID-19.

November 3, 2022

Imspex lands CE Mark for COVID-19 breath test

By LabPulse.com staff writers

A breath analyzer based on a combination of gas chromatography and ion mobility spectrometry technologies, BreathSpec is designed for use in a point-of-care setting by clinicians and nontechnical users in diagnosing respiratory tract infections, with specific utility for COVID-19, according to the Wales-based vendor.

August 8, 2022

Qiagen expands QIAstat-Dx syndromic panel

By LabPulse.com staff writers

QIAstat-Dx Rise is compatible with Qiagen's updated QIAstat-Dx respiratory SARS-CoV-2 panel, the QIAstat-Dx gastrointestinal panel 2, as well as future assays. It provides results in about one hour.

May 15, 2022

Applied BioCode receives EUA for SARS-CoV-2 combo assay

By LabPulse.com staff writers

The assay can simultaneously detect and differentiate between SARS-CoV-2, influenza A with subtypes, and respiratory syncytial virus in nasopharyngeal swab specimens, the company said. The test is designed to assist physicians in evaluating patients with clinical signs and symptoms of respiratory infection.

December 16, 2021

Page 1 of 3

Next Page